C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training

Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):168-72. doi: 10.1097/HJR.0b013e3282f10e9b.

Abstract

Background: C-type natriuretic peptide (CNP) is structurally related to cardiac natriuretic peptides and is currently considered as an endothelium-derived hyperpolarizing factor. Endothelial dysfunction, commonly observed in chronic heart failure (HF) patients is positively affected by physical training.

Methods: To evaluate the effect of aerobic physical training on the expression of CNP, 90 HF patients on optimal pharmacological treatment (age 62+/-2 years, mean+/-SEM), randomly assigned in a 3 : 1 ratio to either control group (C, 19 patients) or home-based aerobic exercise-training program group (T, 71 patients), completed the protocol. Plasma assay of CNP, brain natriuretic peptide or B-type natriuretic peptide (BNP), and norepinephrine; echocardiogram; and cardiopulmonary-stress test were performed in all patients at enrollment and after 9 months.

Results: At baseline, in both groups, CNP plasma level was significantly related to BNP (R=0.50), ejection fraction (R=0.43), and peak oxygen uptake (VO2, R=0.43, all P<0.001). After 9 months, trained patients showed an improvement in peak VO2 (P<0.001) and ejection fraction (P<0.05), whereas norepinephrine (P<0.05), BNP (P<0.001), and CNP (P<0.001) decreased. No changes occurred in group C. In group T, the decrease in CNP was significantly related to the increase in peak VO2 (R=0.31, P<0.01), and the relation between CNP and BNP was preserved at the end of the program (R=0.41, P<0.001).

Conclusion: Clinical and functional improvement after physical training in HF patients is associated with a decrease in adrenergic activation and in both CNP and BNP concentration. Changes in CNP plasma concentration after physical training might reflect an improvement in endothelial function.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Biomarkers / blood
  • Cardiovascular Agents / therapeutic use
  • Chronic Disease
  • Down-Regulation
  • Echocardiography
  • Exercise Test
  • Exercise Therapy*
  • Female
  • Heart Failure / blood
  • Heart Failure / physiopathology
  • Heart Failure / therapy*
  • Humans
  • Male
  • Middle Aged
  • Natriuretic Peptide, Brain / blood
  • Natriuretic Peptide, C-Type / blood*
  • Norepinephrine / blood
  • Oxygen Consumption
  • Prospective Studies
  • Stroke Volume
  • Time Factors
  • Treatment Outcome
  • Ventricular Function, Left

Substances

  • Biomarkers
  • Cardiovascular Agents
  • Natriuretic Peptide, Brain
  • Natriuretic Peptide, C-Type
  • Norepinephrine